Brendan Eckelman
Plus aucun poste en cours
Postes actifs de Brendan Eckelman
Sociétés | Poste | Début | Fin |
---|
Historique de carrière de Brendan Eckelman
Anciens postes connus de Brendan Eckelman
Sociétés | Poste | Début | Fin |
---|---|---|---|
INHIBRX, INC. | Directeur/Membre du Conseil | 01/04/2018 | 27/10/2021 |
Directeur Technique/Scientifique/R&D | - | 30/05/2024 | |
Fondateur | 01/04/2010 | 30/05/2024 | |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Inhibrx LP developed therapeutic antibodies and pharmaceuticals. Its programs focused on oncology, inflammatory and metabolic diseases and these programs are based on an implementation of multiple antibody and biologic development strategies for therapeutic lead generation, selection, functional enhancement, and optimization. The firm's platforms enabled fit-for-function biotherapeutics that interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling. The company was founded by Quinn Deveraux, Brendan Eckelman, and Mark Paul Lappe in 2010 and was headquartered in La Jolla, CA. | Directeur des opérations | 01/01/2010 | - |
Fondateur | 01/01/2010 | - |
Formation de Brendan Eckelman
UC San Diego School of Medicine | Doctorate Degree |
University of California San Diego | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
INHIBRX, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Inhibrx LP developed therapeutic antibodies and pharmaceuticals. Its programs focused on oncology, inflammatory and metabolic diseases and these programs are based on an implementation of multiple antibody and biologic development strategies for therapeutic lead generation, selection, functional enhancement, and optimization. The firm's platforms enabled fit-for-function biotherapeutics that interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling. The company was founded by Quinn Deveraux, Brendan Eckelman, and Mark Paul Lappe in 2010 and was headquartered in La Jolla, CA. | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
- Bourse
- Insiders
- Brendan Eckelman
- Expérience